A survey of clarithromycin monotherapy and long-term administration of ethambutol for patients with MAC lung disease in Japan: A retrospective cohort study using the database of health insurance claims.
Tomohide IwaoGenta KatoIsao ItoEiji AramakiTomohiro KurodaPublished in: Pharmacoepidemiology and drug safety (2019)
CAM monotherapy over a long period of time is potentially detrimental to some patients. Better awareness of the types of treatments and their potential negative effects will be beneficial to clinical practitioners.
Keyphrases
- health insurance
- end stage renal disease
- affordable care act
- newly diagnosed
- ejection fraction
- combination therapy
- helicobacter pylori
- primary care
- chronic kidney disease
- open label
- prognostic factors
- peritoneal dialysis
- randomized controlled trial
- emergency department
- healthcare
- patient reported outcomes
- adverse drug
- climate change
- risk assessment
- electronic health record